#409 скачать в хорошем качестве

#409

Results from the Large Real-World Study of the Prostatic Urethral Lift (PUL) Demonstrate Consistent Safety and Effectiveness for BPH Patients Mueller T1, Eure G2, Gange S3, Walter P4, Khan A5, Chabert C6 1. Delaware Valley Urology, 2. Urology of Virginia, 3. Summit Urology Group, 4. Western New York Urological Associates, 5. Urology Health Center, 6. The Prostate Clinic KEYWORDS: Benign Prostatic Hyperplasia (BPH), Bladder Outlet Obstruction , Retrospective Study Minimally invasive surgical therapy (MIST) for benign prostatic hyperplasia (BPH) is designed to provide effective symptom relief with minimal morbidity. Randomized controlled trials have historically served as the gold standard for demonstrating clinical safety and efficacy, yet inconsistent real-world outcomes have reduced the use of early MISTs such as TUNA and TUMT. The Prostatic Urethral Lift (PUL) is a MIST that has been shown to provide safe, rapid, and durable symptom relief with minimal morbidity for BPH patients. Here, we expand upon effectiveness results from the large, actively enrolling Real World Retrospective (RWR) study of PUL, which continues to support results from clinical studies. Read the full abstract text here: https://www.ics.org/2020/abstract/409